Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 452 of 1,261

  1. US 10517948

    Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy

    The Board of Regents of the University of Texas System · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  2. US 10517942

    Polypeptide glycopeptide fragments from the V1/V2 and V3 domains of the HIV-1 envelope protein gp 120

    The Regents of the University of California · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  3. US 10517950

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  4. US 10517924

    High density lipoprotein nanoparticles for inflammation

    Northwestern University · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  5. US 10517890

    Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  6. US 10517898

    Compositions and methods related to hematologic recovery

    The Regents of the University of California · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  7. US 10517889

    Modulators of SMAD7 expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  8. US 10517874

    sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  9. US 10517869

    Topical brimonidine tartrate ophthalmic solution

    SENTISS PHARMA PRIVATE LIMITED · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  10. US 10517864

    Sustained-release buprenorphine solutions

    Indivior UK Limited · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  11. US 10517853

    Methods for treating epilepsy

    PTC THERAPEUTICS, INC. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  12. US 10517491

    Cardiac phase-resolved non-breath-hold 3-dimensional magnetic resonance angiography

    The Regents of the University of California · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  13. US 10517860

    Combination of pimavanserin and cytochrome P450 modulators

    ACADIA Pharmaceuticals Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  14. US 10517902

    Expandable amnion membrane for treating non-healing wounds

    Prime Merger Sub, LLC · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  15. US 10512672

    Methods for the treatment of inflammatory joint disease

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  16. US 10512673

    Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  17. US 10512671

    IL-24 to treat inflammatory diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  18. US 10512649

    Methods and compositions for treatment of zika virus infection

    BioCryst Pharmaceuticals, Inc. · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  19. US 10512667

    Compositions and methods for treating conditions related to adrenocortical activity and/or excessive steroid production

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  20. US 10512630

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  21. US 10512637

    Use of inhibitor of cystine-glutamate transporter

    China Medical University · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  22. US 10512609

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Jazz Pharmaceuticals Ireland Limited · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  23. US 10513703

    Hepatitis B virus (HBV) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

  24. US 10513712

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.